top of page
GRAIL
GRAIL is a biotechnology company pioneering early cancer detection through blood-based tests powered by genomic sequencing and machine learning.
• Developed the Galleri® test, a commercially available multi-cancer early detection (MCED) test
• Uses proprietary machine learning algorithms to analyze cell-free DNA (cfDNA) for cancer signals
• Detects over 50 types of cancer from a single blood draw with high specificity
• Collaborates with health systems and providers to integrate the test into routine care
• Actively involved in clinical trials and real-world evidence programs to expand adoption
No Reviews YetShare your thoughts.
Be the first to leave a review.
bottom of page